This protocol is judged by an institutional review board, an unbiased team that opinions any medical trials involving people. If a research consists of a Schedule I drug, as soon as the board approves the protocol as ethical, the scientists must apply for an investigational new drug (IND) selection from your FDA.copyright initially grew to become